State of New Jersey Common Pension Fund D Purchases 18,443 Shares of CVS Health Corporation $CVS

State of New Jersey Common Pension Fund D increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 4.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 441,586 shares of the pharmacy operator’s stock after acquiring an additional 18,443 shares during the period. State of New Jersey Common Pension Fund D’s holdings in CVS Health were worth $33,291,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of CVS. Kanawha Capital Management LLC bought a new stake in CVS Health during the 2nd quarter worth about $216,000. Koshinski Asset Management Inc. lifted its position in shares of CVS Health by 40.6% during the second quarter. Koshinski Asset Management Inc. now owns 6,933 shares of the pharmacy operator’s stock worth $478,000 after purchasing an additional 2,003 shares in the last quarter. TrueMark Investments LLC bought a new stake in shares of CVS Health during the second quarter valued at approximately $5,040,000. Independence Asset Advisors LLC acquired a new stake in shares of CVS Health in the second quarter valued at approximately $2,378,000. Finally, Chicago Partners Investment Group LLC raised its position in CVS Health by 15.1% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 16,587 shares of the pharmacy operator’s stock worth $1,144,000 after purchasing an additional 2,176 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS stock opened at $78.45 on Monday. The stock has a market cap of $99.80 billion, a PE ratio of 56.85, a price-to-earnings-growth ratio of 0.82 and a beta of 0.50. The stock has a 50-day moving average of $78.64 and a 200-day moving average of $76.34. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

Analyst Upgrades and Downgrades

CVS has been the subject of several research reports. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Mizuho lifted their price objective on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Wolfe Research upped their target price on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Piper Sandler reaffirmed an “overweight” rating and issued a $101.00 target price (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Finally, The Goldman Sachs Group boosted their price target on shares of CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.